Waverley Pharma Third Quarter 2022 Earnings: CA$0.002 loss per share (vs CA$0.004 loss in 3Q 2021)




  • In Business
  • 2022-11-26 12:35:00Z
  • By Simply Wall St.
 

Waverley Pharma (CVE:WAVE) Third Quarter 2022 Results

Key Financial Results

  • Revenue: CA$341.9k (down 11% from 3Q 2021).

  • Net loss: CA$121.7k (loss narrowed by 41% from 3Q 2021).

  • CA$0.002 loss per share (improved from CA$0.004 loss in 3Q 2021).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Waverley Pharma's share price is broadly unchanged from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 4 warning signs for Waverley Pharma (3 make us uncomfortable) you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You'll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

COMMENTS

More Related News

Transaction Capital Limited
Transaction Capital Limited's (JSE:TCP) Shares May Have Run Too Fast Too Soon

Transaction Capital Limited's ( JSE:TCP ) price-to-earnings (or "P/E") ratio of 16.1x might make it look like a strong...

Investors in My Food Bag Group (NZSE:MFB) have unfortunately lost 62% over the last year
Investors in My Food Bag Group (NZSE:MFB) have unfortunately lost 62% over the last year

The nature of investing is that you win some, and you lose some. And there's no doubt that My Food Bag Group Limited...

Investors in Auswide Bank (ASX:ABA) have unfortunately lost 7.9% over the last year
Investors in Auswide Bank (ASX:ABA) have unfortunately lost 7.9% over the last year

Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that...

Investors in Revenue Group Berhad (KLSE:REVENUE) have unfortunately lost 63% over the last year
Investors in Revenue Group Berhad (KLSE:REVENUE) have unfortunately lost 63% over the last year

Revenue Group Berhad ( KLSE:REVENUE ) shareholders should be happy to see the share price up 13% in the last month. But...

Those who invested in AVITA Medical (ASX:AVH) five years ago are up 147%
Those who invested in AVITA Medical (ASX:AVH) five years ago are up 147%

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business